Technical Analysis for CERC - Cerecor Inc.

Grade Last Price % Change Price Change
grade F 2.97 -12.13% -0.41
CERC closed down 12.13 percent on Thursday, February 27, 2020, on 1.24 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Mar 16
*** please verify all earnings dates ***

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical CERC trend table...

Date Alert Name Type % Chg
Expansion Breakdown Bearish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Lower Bollinger Band Walk Weakness -12.13%
Below Lower BB Weakness -12.13%
Down 3 Days in a Row Weakness -12.13%
Lower Bollinger Band Touch Weakness -12.13%
Oversold Stochastic Weakness -12.13%
New Downtrend Bearish -13.54%
Stochastic Reached Oversold Weakness -13.54%
Below Lower BB Weakness -13.54%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Cerecor, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs for the treatment of patients with neurological and psychiatric disorders. The company has a portfolio of clinical and preclinical compounds, such as CERC-301, CERC-501, and CERC-406. It develops CERC-301 that is in Phase II development stage as an oral, adjunctive antidepressant for the treatment of patients with major depressive disorder (MDD); CERC-501, which is in Phase II development, for co-occurring psychiatric and substance use disorders; and CERC-406 that is its preclinical lead candidate that inhibit catechol-O-methyltransferase within the brain, as well as anticipates developing CERC-406 for the treatment of residual cognitive impairment symptoms in patients with MDD. The company was formerly known as Ceregen Corporation and changed its name to Cerecor Inc. in March 2011. Cerecor, Inc. was founded in 2011 and is headquartered in Baltimore, Maryland.
Chemistry Biopharmaceutical Disorders Organic Chemistry Major Depressive Disorder Depression Pyrrolidines Antidepressants Piperidines Nmda Receptor Antagonists

Is CERC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 6.87
52 Week Low 2.91
Average Volume 101,154
200-Day Moving Average 4.09
50-Day Moving Average 4.43
20-Day Moving Average 3.90
10-Day Moving Average 3.73
Average True Range 0.31
ADX 30.31
+DI 10.28
-DI 39.21
Chandelier Exit (Long, 3 ATRs ) 3.67
Chandelier Exit (Short, 3 ATRs ) 3.88
Upper Bollinger Band 4.54
Lower Bollinger Band 3.26
Percent B (%b) -0.23
BandWidth 32.83
MACD Line -0.27
MACD Signal Line -0.19
MACD Histogram -0.0834
Fundamentals Value
Market Cap 77.37 Million
Num Shares 26.1 Million
EPS -1.12
Price-to-Earnings (P/E) Ratio -2.65
Price-to-Sales 24.44
Price-to-Book 4.41
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.60
Resistance 3 (R3) 3.67 3.53 3.50
Resistance 2 (R2) 3.53 3.37 3.49 3.46
Resistance 1 (R1) 3.25 3.27 3.18 3.18 3.43
Pivot Point 3.10 3.10 3.07 3.07 3.10
Support 1 (S1) 2.83 2.94 2.75 2.76 2.51
Support 2 (S2) 2.68 2.84 2.65 2.48
Support 3 (S3) 2.40 2.68 2.44
Support 4 (S4) 2.34